Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Broughton Nicotine Services is the former name of Broughton Life Sciences, a UK-based independent life sciences CRO focused on analytical testing, scientific consultancy, and regulatory compliance. The business supports next-generation nicotine products, pharmaceuticals, medicinal cannabis, CBD, and related healthcare products with GMP-compliant and ISO/IEC 17025-accredited laboratory services. In nicotine, it provides analytical chemistry, toxicology, environmental assessment, clinical-trial support, and regulatory services for e-vapour products, heated tobacco products, nicotine pouches, and nicotine replacement therapies. The company works with clients across the UK, Europe, North America, the Middle East, Asia, and Australia and positions itself as a partner for bringing regulated products to market. Its business is service-based rather than centered on an internal therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Broughton Nicotine Services.